PERKINELMER INC (PKI) Stock Fundamental Analysis
USA - NYSE:PKI - US7140461093 - Common Stock
115.24 USD
-1.06 (-0.91%)
115.24 USD
0 (0%)
PKI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. While PKI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year PKI was profitable.
In the past year PKI had a positive cash flow from operations.
Each year in the past 5 years PKI has been profitable.
PKI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 5.28%, PKI is doing good in the industry, outperforming 76.19% of the companies in the same industry.
PKI has a better Return On Equity (10.11%) than 77.78% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.49%, PKI is in the better half of the industry, outperforming 73.02% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PKI is significantly above the industry average of 14.93%.
The 3 year average ROIC (52.37%) for PKI is well above the current ROIC(6.49%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 16.32%, PKI belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
PKI's Profit Margin has improved in the last couple of years.
PKI's Operating Margin of 23.43% is amongst the best of the industry. PKI outperforms 88.89% of its industry peers.
PKI's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 58.39%, PKI is doing good in the industry, outperforming 76.19% of the companies in the same industry.
In the last couple of years the Gross Margin of PKI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PKI is creating value.
The number of shares outstanding for PKI remains at a similar level compared to 1 year ago.
The debt/assets ratio for PKI has been reduced compared to a year ago.
2.2 Solvency
PKI has an Altman-Z score of 2.51. This is not the best score and indicates that PKI is in the grey zone with still only limited risk for bankruptcy at the moment.
PKI has a Altman-Z score (2.51) which is comparable to the rest of the industry.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.40, PKI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
PKI has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: PKI underperforms 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
A Current Ratio of 2.13 indicates that PKI has no problem at all paying its short term obligations.
PKI has a Current ratio of 2.13. This is in the lower half of the industry: PKI underperforms 68.25% of its industry peers.
PKI has a Quick Ratio of 1.87. This is a normal value and indicates that PKI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PKI (1.87) is worse than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
The earnings per share for PKI have decreased strongly by -30.47% in the last year.
PKI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.15% yearly.
The Revenue has decreased by -3.37% in the past year.
PKI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
3.2 Future
PKI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.04% yearly.
PKI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.60% yearly.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.51, PKI is valued correctly.
Based on the Price/Earnings ratio, PKI is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PKI to the average of the S&P500 Index (27.69), we can say PKI is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, PKI is valued a bit cheaper than 77.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, PKI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PKI is valued cheaper than 93.65% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PKI is valued cheaper than 87.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
PKI has an outstanding profitability rating, which may justify a higher PE ratio.
PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
No dividends for PKI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.56%
Inst Owner Change-0.02%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | 3.19 | ||
| P/FCF | 24.52 | ||
| P/OCF | 21.43 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | N/A | ||
| ROIC | 6.49% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 35.96% | ||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0.99%
ROICexcg growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 79.63% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.51 |
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%